Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00565487
Recruitment Status : Completed
First Posted : November 30, 2007
Last Update Posted : May 21, 2018
Genentech, Inc.
Information provided by (Responsible Party):
Milton S. Hershey Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 5, 2014
  Actual Study Completion Date : August 5, 2014